Birth Defects Attorneys

By admin | Published November 23, 2011

Birth Defects Attorneys (11/23/11): Birth defects occur frequently, but it’s a possibility that the antidepressant or SSRI you were taking is responsible for your child’s birth defect. If you believe the drug you were taking caused your child’s birth defect or premature death, you should contact Birth Defects Attorneys. Birth Defects Attorneys understand the effects ranging from heart and lung problems to limb abnormalities. Birth Defects Attorneys can help you receive compensation for the costly surgeries your child may have experienced as a result of a birth defect. Call Best Legal Source at 800 611 7080 or fill out the form to your right to be put in touch with seasoned, professional Birth Defects Attorneys.

1-800-611-7080

Birth Defects Attorneys understand the process of taking on powerful drug companies. Birth Defects Attorneys know the severity of effects these drugs can cause. Antidepressants have been linked to withdrawal symptoms, cardiac defects, ventricular septal and atrial septal defects. If your child was fatally harmed or permanently injured because of an SSRI like Paxil, Zoloft or Cymbalta, then you deserve the representation of Birth Defects Attorneys. Birth Defects Attorneys are experienced with the litigation involved in these cases and can help you get the justice you deserve. Each day you let pass without filing could be critical to your case. It is crucial that you call Best Legal Source today and begin conversations with Birth Defects Attorneys.

Birth Defects Attorneys is a term used to describe the area of practice that these attorneys are familiar with. Our intent is not to deceive the public. Birth Defects Attorneys is not used to insinuate that Best Legal Source has any connection with a particular drug company. Best Legal Source has no affiliation with any drug manufacturer. Our mission is simply to connect you with Birth Defects Attorneys.

Birth Defects Attorneys are able to give you the respect and compassion needed for birth defect cases. They understand that you and your child have gone through extreme emotional and physical pain. Birth Defects Attorneys know the facts and can deliver the results you deserve. Call Best Legal Source today to begin conversation with Birth Defects Attorneys. Now is the time to pursue your case.

1-800-611-7080

Birth Defects Lawsuit

By admin | Published November 21, 2011

Birth Defects Lawsuit
A German pharmaceutical company introduced a new sedative-hypnotic agent of considerable promise, Contergan, as an over-the-counter (OTC) drug in 1957 in 46 countries; the United States
was not included. Over the next 4 years, deformed children were reported from some 30 of these markets. By 1962 when the drug was removed from the market, it left in its wake about 8000
children characterized with phocomelia of the arms and legs and various other birth defects. That drug, generically named thalidomide, is thus the prototype human teratogen. This experience provided the impetus for present day testing for development and reproduction in animal models as a result of the Kefauver-Harris Drug Amendments of 1962,* which were to follow. The history’ of thalidomide is worth telling and retelling, and serves as a perpetual reminder over three decades later, of the possible tcratogenic hazards of drugs and chemicals.

In December 1959 at a meeting in Germany, a pediatrician named Weidenbach presented the case history of a deformed female baby born in November 1958. In that case, the upper and lower limbs were missing, the hands and feet originating directly from the shoulder and pelvic girdles, respectively; the digits were also deformed. A hereditary factor was considered the most likely cause of
the defect. Nine months later, in September 1960, two German physicians, Kosenow and Pfeiffer presented a scientific exhibit at a meeting of the German Society of Pediatrics in Kassel in which they described two infants with similar malformations. Little attention was paid to the exhibit and no association was made between the two events.

One year later, on September 16, 1961, another German scientist, Wiedemann, published a scientific paper delineating the clinical syndrome, calling attention to the present increase in the incidence of hypoplastic and aplastic malformations (phocomelia) of the extremities. He alluded to a total of some 13 cases he had seen personally over the past 10 months. This was the first publication alarming the scientific world to the defect. Although not a single case of phocomelia had been
* Public Law 87-781.

To keep track of Birth Defect Attorney news subscribe to our RSS feed.

Birth Defects Attorneys

By admin | Published November 21, 2011

Birth Defects Attorneys
Then the drugs carbamazepine and the mcthadiones, in which the probable level of their hazard, although as high as 80% among individuals analyzed, is countered by their more-limited clinical usage. Next there is valproic acid, its effects in 1-2% of offspring of mothers delivering while taking the drug according to best estimates. Finally, there is primidone and phenobarbital-related drugs in which fetal syndromes have been reported, but reliable estimates of the frequency of these are not known.

Given the dilemma of the teratogenicity of at least some of the anticonvulsant medications that may be important therapy for many women, Smith (1977a) attempted to define the risks inherent to the pregnant epileptic. While admitting a high teratogenic risk for the oxazolidinediones, in contrast to what he termed a 10% risk of serious problems with hydantoins, he stated that women taking either should have the option of terminating their pregnancies if they occur while taking the drugs.
Avoidance of the barbiturate types was also suggested, and his final recommendation was the discontinuance of anticonvulsam medication before pregnancy, if at all possible. Beasley and Landstrom (1977) and Swaiman (1980) agreed that management of the pregnant, epileptic should aim toward reduction of all possible risk factors. In spite of this level of concern, litigation has proceeded in the courts with both phenytohi and primidone. In addition, the mental competence of a teenager in criminal court in a recent case was questioned on the basis of his mother being medicated with trimethadione during her pregnancy.

Hill (1979) took exception to Smith’s suggestion that women should consider termination of pregnancy if conceived while treated with hydantoins. She reported in editorial fashion on the follow- up of 47 infants from birth to 9 years of age who were born under maternal anticonvulsant use, and her results were more optimistic than Smith’s. Although admitting the occurrence for congenital malformations and lower mental performance in a higher frequency than in the general population, she stated that the mother who requires an anticonvulsant drug during pregnancy has an 80-90% chance of having a physically sound baby with normal intelligence. Furthermore, 10-20% of the infants who have major malformations are treatable.

For more information on Birth Defects subscribe to out RSS feed.

Posted in Birth Defect, Birth Defects Attorneys | Tagged Birth Defect, Birth Defect Attorneys, Birth Defects Attorneys |

Birth Defects

Birth Defects Attorneys

Birth Defects Lawsuit

Birth Defects Attorneys

Contact Form

Questions? Advice?

Sitemap